Objectives

After participating in this educational activity, attendees should be able to:

  1. Understand the utility of GLP1 agonists in type 2 diabetes mellitus treatment
  2. Understand the dual mechanism of action of Tirzepatide
  3. Evaluate the efficacy and safety of tirzepatide versus semaglutide
Faculty
Hailey Chapdelaine, PharmD
Pharmacist
PGY1 Pharmacy Resident
Baystate Medical Center

 

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.

                                                                         

Session date: 
Monday, August 30, 2021 - 2:00pm to 3:00pm
Location: 
Baystate Medical Center
759 Chestnut St.
Live via Webex
Springfield, MA 01199
United States
  • 1.00 ACPE Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.